NCT05792397View on ClinicalTrials.gov

TwiFlow Thrombectomy Catheter sYstem for Acute Pulmonary Embolism (Twi-TYPE Study)

NANot yet recruitingINTERVENTIONAL

Enrollment

127

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

May 1, 2024

Study Completion Date

May 1, 2026

Conditions

Acute Pulmonary Embolism

Interventions

DEVICE

TwiFlow-Thrombectomy Catheter System

Patients with acute pulmonary embolism and meeting the conditions of this clinical trial will accept the pulmonary embolism removal operation by the novel device named 'TwiFlow-Thrombectomy Catheter System'

All Listed Sponsors

lead

Morningside (Nantong) Medical Co.,Ltd

OTHER

NCT05792397 - TwiFlow Thrombectomy Catheter sYstem for Acute Pulmonary Embolism (Twi-TYPE Study) | Biotech Hunter | Biotech Hunter